scorecardresearch
Wednesday, July 23, 2025
TopicMaiden Pharmaceuticals

Topic: Maiden Pharmaceuticals

India to take ‘appropriate action’ after cough syrup bribe probe linked to child deaths in Gambia

WHO linked the syrups made by India's Maiden Pharmaceuticals to the deaths of 70 children in 2022, though govt stated that subsequent lab tests showed the syrups were not toxic.

Govt considering proposal to test cough syrups before export, reports News18

The CDSCO has also proposed making it mandatory for exporters to produce a 'certificate of analysis' of batches exported from an approved laboratory, the news outlet reported.

Haryana court convicts two pharma executives for exporting substandard drugs to Vietnam

Founder Naresh Kumar Goel & Technical Director M.K. Sharma of Maiden Pharmaceuticals have been sentenced to two-and-half years in jail.

Cough syrups by Maiden Pharma is of standard quality, says govt after probe into Gambia deaths

The Centre's statement comes weeks after the WHO alerted that the firm’s cough syrups could potentially be linked to the death of 66 children in Gambia.

Indonesia says 74 kids have died from acute kidney injury this year, following deaths in Gambia

Nearly 70 children had died from the same illness in Gambia after taking a paracetamol syrup. The WHO had 'potentially' linked their deaths to cough syrups manufactured in India.

Will take ‘strict action’ if cough syrup proved to be behind Gambia deaths, says Anil Vij

Haryana health minister said the government has sent cough syrup samples to central pharmaceutical laboratory for testing after deaths of 66 children in the West African country.

On Camera

Bihar mimics 19th-century American South. Citizenship is now weaponised to exclude voters

Disenfranchisement by institutional fiat is profoundly undemocratic. The effect of the ECI's new documentary process in Bihar will tilt the scales in favour of the BJP.

India-US set to ink mini trade deal soon, reach understanding on agricultural & dairy products

Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.

Not just AK-203, India & Russia to jointly manufacture AK-19 and PPK-20 for domestic use and export 

India-Russia JV is also racing to deliver 7,000 more AK-203 assault rifles by 15 Aug. These are currently being made with 50% indigenisation and this will surge to 100% by 31 December.

Strategic partner one day, tactical nightmare the next: India’s learning Trumplomacy the hard way

Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.